Amwell vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
B2B telehealth infrastructure for health systems with $275M revenue; white-label digital care platform with AI Automated Care Programs for chronic disease management.
About
Amwell (American Well) is a telehealth platform company providing virtual care infrastructure for health systems, payers, employers, and government agencies — enabling digital health visits across primary care, urgent care, behavioral health, specialty care, and automated care programs. Founded in 2006 in Boston by Roy and Ido Schoenberg and listed on NYSE in 2020, Amwell generates approximately $275 million in annual revenue serving over 2,000 health systems, 80+ health plan clients, and 80+ government programs.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.